Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Intangibles (2020 - 2025)

Maravai Lifesciences Holdings (MRVI) has 5 years of Intangibles data on record, last reported at $195.0 million in Q4 2024.

  • For Q4 2024, Intangibles fell 11.78% year-over-year to $195.0 million; the TTM value through Dec 2024 reached $195.0 million, down 11.78%, while the annual FY2024 figure was $195.0 million, 11.78% down from the prior year.
  • Intangibles reached $195.0 million in Q4 2024 per MRVI's latest filing, down from $201.9 million in the prior quarter.
  • Across five years, Intangibles topped out at $241.6 million in Q1 2023 and bottomed at $2.9 million in Q1 2020.
  • Average Intangibles over 5 years is $182.8 million, with a median of $207.2 million recorded in 2024.
  • Peak YoY movement for Intangibles: soared 5852.28% in 2021, then dropped 11.78% in 2024.
  • A 5-year view of Intangibles shows it stood at $2.9 million in 2020, then skyrocketed by 3954.17% to $117.6 million in 2021, then surged by 84.28% to $216.7 million in 2022, then grew by 2.0% to $221.0 million in 2023, then dropped by 11.78% to $195.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Intangibles were $195.0 million in Q4 2024, $201.9 million in Q3 2024, and $207.2 million in Q2 2024.